Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Can J Physiol Pharmacol ; 88(2): 130-40, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20237587

RESUMEN

In dystrophin-deficient skeletal muscle cells, in which Ca2+ homeostasis is disrupted and reactive oxygen species production is increased, we hypothesized that hypochlorous acid (HOCl), a strong H2O2-related free radical, damages contractile proteins and the sarcoplasmic reticulum. The aim of the present study was to investigate the effects of exposure to oxidative stress, generated by applying HOCl (100 micromol/L and 1 mmol/L), on the contractile function and sarcoplasmic reticulum properties of dystrophic mice. Experiments were performed on diaphragm muscle, which is severely affected in the mdx mouse, and the results were compared with those obtained in healthy (non-dystrophic) mice. In Triton-skinned fibres from C57BL/10 and mdx mice, 1 mmol/L HOCl increased myofibrillar Ca2+ sensitivity, but decreased maximal Ca2+-activated tension. In the presence of HOCl, higher concentrations of MgATP were required to produce rigor tensions. The interaction between HOCl and the Ca2+ uptake mechanisms was demonstrated using saponin-skinned fibres and sarcoplasmic reticulum vesicles. The results showed that HOCl, at micromolar or millimolar concentrations, can modify sarcoplasmic reticulum Ca2+ uptake and that this effect was more pronounced in diaphragm muscle from mdx mice. We conclude that in dystrophic diaphragm skeletal muscle cells, HOCl activates a cellular pathway that leads to an increase in the intracellular concentration of Ca2+.


Asunto(s)
Diafragma/efectos de los fármacos , Ácido Hipocloroso/farmacología , Contracción Muscular/efectos de los fármacos , Distrofia Muscular Animal/metabolismo , Distrofia Muscular Animal/fisiopatología , Oxidantes/farmacología , Animales , Calcio/metabolismo , Diafragma/fisiología , Diafragma/fisiopatología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos mdx , Contracción Muscular/fisiología , Distrofia Muscular Animal/genética , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/fisiología , Retículo Sarcoplasmático/efectos de los fármacos , Retículo Sarcoplasmático/genética , Retículo Sarcoplasmático/metabolismo
2.
Neuromuscul Disord ; 21(5): 313-27, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21392993

RESUMEN

Duchenne muscular dystrophy, a genetic disease caused by the absence of functional dystrophin, remains without adequate treatment. Although great hopes are attached to gene and cell therapies, identification of active small molecules remains a valid option for new treatments. We have studied the effect of 20 approved pharmaceutical compounds on the muscles of dystrophin-deficient mdx5Cv mice. These compounds were selected as the result of a prior screen of 800 approved molecules on a dystrophin mutant of the invertebrate animal model Cænorhabditis elegans. Drugs were administered to the mice through maternal feeding since 2weeks of life and mixed in their food after the 3rd week of life. The effects of the drugs on mice were evaluated both at 6weeks and 16weeks. Each drug was tested at two concentrations. Prednisone was added to the molecule list as a positive control. To investigate treatment efficiency, more than 30 histological, biochemical and functional parameters were recorded. This extensive study reveals that tricyclics (Imipramine and Amitriptyline) are beneficial to the fast muscles of mdx mice. It also highlights a great variability of responses according to time, muscles and assays.


Asunto(s)
Aprobación de Drogas/métodos , Evaluación Preclínica de Medicamentos/métodos , Distrofia Muscular de Duchenne/tratamiento farmacológico , Animales , Creatina Quinasa/sangre , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Composición de Medicamentos , Distrofina/genética , Técnicas In Vitro , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos mdx , Contracción Muscular/efectos de los fármacos , Fibras Musculares Esqueléticas/efectos de los fármacos , Fibras Musculares Esqueléticas/fisiología , Músculos/efectos de los fármacos , Músculos/patología , Distrofia Muscular de Duchenne/sangre , Distrofia Muscular de Duchenne/patología
3.
J Cell Physiol ; 213(2): 464-74, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17516551

RESUMEN

Junctate is an integral sarco(endo)plasmic reticulum protein expressed in many tissues including heart and skeletal muscle. Because of its localization and biochemical characteristics, junctate is deemed to participate in the regulation of the intracellular Ca2+ concentration. However, its physiological function in muscle cells has not been investigated yet. In this study we examined the effects of junctate over-expression by generating a transgenic mouse model which over-expresses junctate in skeletal muscle. Our results demonstrate that junctate over-expression induced a significant increase in SR Ca2+ storage capacity which was paralleled by an increased 4-chloro-m-cresol and caffeine-induced Ca2+ release, whereas it did not affect SR Ca2+-dependent ATPase activity and SR Ca2+ loading rates. In addition, junctate over-expression did not affect the expression levels of SR Ca2+ binding proteins such as calsequestrin, calreticulin and sarcalumenin. These findings suggest that junctate over-expression is associated with an increase in the SR Ca2+ storage capacity and releasable Ca2+ content and support a physiological role for junctate in intracellular Ca2+ homeostasis.


Asunto(s)
Proteínas de Unión al Calcio/metabolismo , Calcio/metabolismo , Proteínas de la Membrana/metabolismo , Oxigenasas de Función Mixta/metabolismo , Proteínas Musculares/metabolismo , Músculo Esquelético , Retículo Sarcoplasmático/metabolismo , Animales , Proteínas de Unión al Calcio/genética , ATPasas Transportadoras de Calcio/metabolismo , Genotipo , Homeostasis , Proteínas de la Membrana/genética , Ratones , Ratones Transgénicos , Oxigenasas de Función Mixta/genética , Proteínas Musculares/genética , Músculo Esquelético/fisiología , Músculo Esquelético/ultraestructura
4.
Exp Cell Res ; 313(5): 997-1007, 2007 Mar 10.
Artículo en Inglés | MEDLINE | ID: mdl-17275812

RESUMEN

We have previously reported that CD34(+) cells purified from mouse fetal muscles can differentiate into skeletal muscle in vitro and in vivo when injected into muscle tissue of dystrophic mdx mice. In this study, we investigate the ability of such donor cells to restore dystrophin expression, and to improve the functional muscle capacity of the extensor digitorum longus muscle (EDL) of mdx mice. For this purpose green fluorescent-positive fetal GFP(+)/CD34(+) cells or desmin(+)/(-)LacZ/CD34(+) cells were transplanted into irradiated or non-irradiated mdx EDL muscle. Donor fetal muscle-derived cells predominantly fused with existing fibers. Indeed more than 50% of the myofibers of the host EDL contained donor nuclei delivering dystrophin along 80-90% of the length of their sarcolemma. The presence of significant amounts of dystrophin (about 60-70% of that found in a control wild-type mouse muscle) was confirmed by Western blot analyses. Dystrophin expression also outcompeted that of utrophin, as revealed by a spatial shift in the distribution of utrophin. At 1 month post-transplant, the recipient muscle appeared to have greater resistance to fatigue than control mdx EDL muscle during repeated maximal contractions.


Asunto(s)
Antígenos CD34/metabolismo , Células Musculares/trasplante , Distrofia Muscular Animal/terapia , Animales , Fusión Celular , Desmina/metabolismo , Distrofina/metabolismo , Fatiga/inducido químicamente , Femenino , Proteínas Fluorescentes Verdes/genética , Operón Lac , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos mdx , Células Musculares/fisiología , Músculos/embriología , Músculos/efectos de la radiación
5.
J Pharmacol Exp Ther ; 318(3): 1359-67, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16801456

RESUMEN

The aim of the present study was to investigate the direct effects of a reactive oxygen species, H(2)O(2), on the contractile function and sarcoplasmic reticulum properties of dystrophin-deficient diaphragm using chemically skinned fibers and sarcoplasmic reticulum vesicle preparations. The results obtained using Triton X-100-skinned fibers demonstrate that exposure to 1 mM H(2)O(2) had similar effects on the maximal Ca(2+)-activated tension and on the Ca(2+) sensitivity of the contractile apparatus of diaphragm fibers in Bl10 and mdx mice. The effects of H(2)O(2) were also assessed on sarcoplasmic reticulum function using saponin-skinned fibers and sarcoplasmic reticulum vesicle preparations. We found that H(2)O(2) induced changes in sarcoplasmic reticulum properties, particularly in the Ca(2+) pump function. The most important finding was that diaphragm muscle from mdx mice displayed increased sensitivity to the oxidant. Furthermore, in isolated superfused diaphragm muscle from mdx mice, the data demonstrate that the amount of superoxide anion produced under fatiguing conditions was increased. Our study shows that the sarcoplasmic reticulum, and the Ca(2+) pump in particular, in dystrophin-deficient muscles display increased susceptibility to H(2)O(2) injuries. This suggests that free radicals might, therefore, be involved in the pathophysiological pathway and dysregulation of Ca(2+) homeostasis of muscular dystrophy.


Asunto(s)
Peróxido de Hidrógeno/toxicidad , Contracción Muscular/efectos de los fármacos , Distrofias Musculares/metabolismo , Retículo Sarcoplasmático/efectos de los fármacos , Animales , Cafeína/farmacología , Calcio/metabolismo , ATPasas Transportadoras de Calcio/metabolismo , Proteínas Contráctiles/análisis , Diafragma , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos mdx , Octoxinol/farmacología , Saponinas/farmacología , Retículo Sarcoplasmático/metabolismo , Superóxidos/metabolismo
6.
Pflugers Arch ; 444(5): 634-43, 2002 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12194017

RESUMEN

The aim of the present study was to establish whether alterations in sarcoplasmic reticulum function are involved in the abnormal Ca(2+) homeostasis of skeletal muscle in mice with muscular dystrophy ( mdx). The properties of the sarcoplasmic reticulum and contractile proteins of fast- and slow-twitch muscles were therefore investigated in chemically skinned fibres isolated from the extensor digitorum longus (EDL) and soleus muscles of normal (C57BL/10) and mdx mice at 4 and 11 weeks of development. Sarcoplasmic reticulum Ca(2+) uptake, estimated by the Ca(2+) release following exposure to caffeine, was significantly slower in mdx mice, while the maximal Ca(2+) quantity did not differ in either type of skeletal muscle at either stage of development. In 4-week-old mice spontaneous sarcoplasmic reticulum Ca(2+) leakage was observed in EDL and soleus fibres and this was more pronounced in mdx mice. In addition, the maximal Ca(2+)-activated tension was smaller in mdx than in normal fibres, while the Ca(2+) sensitivity of the contractile apparatus was not significantly different. These results indicate that mdx hindlimb muscles are affected differently by the disease process and suggest that a reduced ability of the Ca(2+)-ATPase to load Ca(2+) and a leaky sarcoplasmic reticulum membrane may be involved in the altered intracellular Ca(2+) homeostasis.


Asunto(s)
Fibras Musculares de Contracción Rápida/metabolismo , Fibras Musculares de Contracción Lenta/metabolismo , Músculo Esquelético/fisiología , Distrofia Muscular Animal/metabolismo , Retículo Sarcoplasmático/metabolismo , Animales , Cafeína/farmacología , Calcio/metabolismo , Calcio/farmacocinética , Relación Dosis-Respuesta a Droga , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos mdx , Contracción Muscular/efectos de los fármacos , Contracción Muscular/fisiología , Músculo Esquelético/citología , Distrofia Muscular Animal/fisiopatología , Inhibidores de Fosfodiesterasa/farmacología , Soporte de Peso
7.
Am J Physiol Regul Integr Comp Physiol ; 282(4): R1164-73, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11893622

RESUMEN

The present study was designed to examine whether changes in Ca(2+) release by inositol-1,4,5-trisphosphate (IP(3)) in 8-, 15-, and 30-day-old rat skeletal muscles could be associated with the expression of IP(3) receptors. Experiments were conducted in slow-twitch muscle in which both IP(3)-induced Ca(2+) release and IP(3)-receptor (IP(3)R) expression have been shown to be larger than in fast-twitch muscle. In saponin-skinned fibers, IP(3) induced transient contractile responses in which the amplitude was dependent on the Ca(2+)-loading period with the maximal IP(3) contracture being at 20 min of loading. The IP(3) tension decreased during postnatal development, was partially inhibited by ryanodine (100 microM), and was blocked by heparin (20-400 microg/ml). Amplification of the DNA sequence encoding for IP(3)R isoforms (using the RT-PCR technique) showed that in slow-twitch muscle, the type 2 isoform is mainly expressed, and its level decreases during postnatal development in parallel with changes in IP(3) responses in immature fibers. IP(3)-induced Ca(2+) release would then have greater participation in excitation-contraction coupling in developing fibers than in mature muscle.


Asunto(s)
Canales de Calcio/genética , Canales de Calcio/metabolismo , Inositol 1,4,5-Trifosfato/metabolismo , Músculo Esquelético/crecimiento & desarrollo , Músculo Esquelético/metabolismo , Receptores Citoplasmáticos y Nucleares/genética , Receptores Citoplasmáticos y Nucleares/metabolismo , Factores de Edad , Animales , Anticoagulantes/farmacología , Cafeína/farmacología , Calcio/metabolismo , Detergentes , Expresión Génica/fisiología , Heparina/farmacología , Receptores de Inositol 1,4,5-Trifosfato , Contracción Muscular/efectos de los fármacos , Contracción Muscular/fisiología , Fibras Musculares de Contracción Lenta/metabolismo , Músculo Esquelético/citología , Octoxinol , Inhibidores de Fosfodiesterasa/farmacología , ARN Mensajero/análisis , Ratas , Ratas Wistar , Rianodina/farmacología , Canal Liberador de Calcio Receptor de Rianodina/genética , Retículo Sarcoplasmático/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA